ODAC rejects Allos's SR13

FDA's Oncologic Drugs Advisory Committee voted 16-1 Monday that ALTH has not demonstrated the efficacy of RSR13 efaproxiral as an adjunct to whole brain radiation therapy (WBRT) to treat brain metasta...